Back

Skeletal muscle mitochondrial oxidative phosphorylation capacity is associated with aerobic capacity and neuromuscular performance in patients with heart failure with preserved ejection fraction

9 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Frailty and skeletal muscle function in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Ms Andrea Martinez Dominguez

University of Navarra, Pamplona (Spain)

5 More presentations in this session

Presentation thumbnail
Effects of a 12-week supervised multicomponent training on skeletal muscle mitochondrial function in patients with heart failure with preserved ejection fraction
Miss A. Martinez Dominguez (Pamplona, ES)
Abstract Slides
Presentation thumbnail
More than muscle loss: sarcopenia as a marker of disease severity in ambulatory heart failure
Mrs S. Gonzalez Sosa (Palmas de Gran Canaria, Las, ES)
Abstract Slides
Presentation thumbnail
Skeletal muscle fatty acid oxidation capacity independently associates with cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
Miss A. Martinez Dominguez (Pamplona, ES)
Abstract Slides
Presentation thumbnail
Exercise capacity and hemodynamic response during exercise depend on the extent of left ventricular remodeling in patients with HFrEF
Doctor A. Ntalianis (Athens, GR)
Abstract Slides
Presentation thumbnail
Sympathetic nervous system drive assessed by direct muscle sympathetic nerve activity in heart failure: first-in-human insights into autonomic regulation in acute vs. chronic states
Mrs A. Mikolajczak (Wroclaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Frailty and skeletal muscle function in heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources